BlackRock Health Sciences Trust
Research BlackRock Health Sciences Trust (BME) on Bullrun: dividend yield 6.8%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerBME
- ExchangeNYSE
- CountryUnited States
- SectorFinancial Services
- IndustryAsset Management
- CurrencyUSD
- Dividend yield6.8%
- Financial periodQ4 2025
Valuation Snapshot
dividend yield is 6.8%.
Peer valuation comparison
Latest dividend yield is 6.84% versus a Financial Services sector median of 3.86% (77.4% above).
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | n/a | n/a | 6.8% | 3.14 |
| 2025 | 2025-12-31 | n/a | n/a | 7.6% | 3.12 |
| 2024 | 2024-12-31 | n/a | n/a | 6.8% | 2.57 |
| 2023 | 2023-12-29 | n/a | n/a | 6.2% | 2.52 |
| 2022 | 2022-12-30 | n/a | n/a | 5.8% | 2.52 |
| 2021 | 2021-12-31 | n/a | n/a | 5.0% | 2.43 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 3.14 USD, yield 6.8%.
About BlackRock Health Sciences Trust
BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc. The fund is managed by BlackRock Advisors, LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating in the health sciences and related sectors, which include businesses involved in researching, developing, producing, distributing or delivering medical, dental, optical, pharmaceutical or biotechnology products, supplies, equipment, or services.
Related stock research
Other Financial Services stocks
Frequently asked questions
Does BlackRock Health Sciences Trust pay a dividend?
BlackRock Health Sciences Trust has a dividend yield of 6.8%.
What does BlackRock Health Sciences Trust do?
BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc. The fund is managed by BlackRock Advisors, LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating in the health sciences and related sectors, which include businesses involved in researching, developing, producing, distributing or delivering medical, dental, optical, pharmaceutical or biotechnology products, supplies, equipment, or services. It also invests through equity derivatives, with an emphasis on option writing.